| Cash Flow | 2025-09-30 | 2025-06-30 |
|---|---|---|
| Net loss | -17,402 | -14,763 |
| Depreciation and amortization | 120 | 62 |
| Impairment of intangible asset | 152 | - |
| Share-based compensation expense | 539 | 324 |
| Accretion expense on convertible promissory note | 126 | 126 |
| Change in derivative fair value | -9,369 | -9,369 |
| Loss on settlement of convertible promissory note | -1,353 | -1,353 |
| Loss on shares issued for debt | -217 | -217 |
| Expense recognized from prepaid credits used originally issued with shares | 601 | - |
| Shares issued for consulting services | 32 | 32 |
| Change in receivables | 18 | 31 |
| Change in prepaid expenses | -245 | 67 |
| Change in inventory | 9 | 37 |
| Change in trade payables | -632 | -475 |
| Change in accrued liabilities | -1,058 | -1,184 |
| Drawdown in shares issued for prepaid services | - | 140 |
| Change in deferred revenue | -24 | 33 |
| Product enhancement intangible asset | - | 0 |
| Net cash used in operating activities | -6,389 | -4,901 |
| Acquisition of new business, net of cash acquired | 2,360 | 2,360 |
| Purchase of equipment | 105 | 19 |
| Net cash used in investing activities | -2,465 | -2,379 |
| Proceeds from sale of shares, net of issuance costs | 2,531 | 2,560 |
| Proceeds from exercise of warrants | 8,838 | 8,828 |
| Net cash provided by financing activities | 11,369 | 11,388 |
| Increase (decrease) in cash | 2,515 | 4,108 |
| Cash and cash equivalents at beginning of period | 1,810 | - |
| Cash and cash equivalents at end of period | 4,325 | - |
FIREFLY NEUROSCIENCE, INC. (AIFF)
FIREFLY NEUROSCIENCE, INC. (AIFF)